Available Clinical Trials
Displaying All Clinical Trials (72)
A011202
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection …
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection …
A011801
A011801 - The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response …
A011801 - The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response …
A021502
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
A031501
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031704
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
A041501
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041701
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041702
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A051301
A051301 - A randomized double-blind phase III study of ibrutinib …
A051301 - A randomized double-blind phase III study of ibrutinib …
A051701
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A081801
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST …
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST …
A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
A211601 Companion to A011502
Evaluation of Mammographic Breast Density Effect of Aspirin: A companion …
Evaluation of Mammographic Breast Density Effect of Aspirin: A companion …
A221505
A221505 - RT CHARM: Phase III Randomized Trial of Hypofractionated …
A221505 - RT CHARM: Phase III Randomized Trial of Hypofractionated …
AGCT1531
AGCT1531: A Phase 3 Study of Active Surveillance for Low …
AGCT1531: A Phase 3 Study of Active Surveillance for Low …
AMG 510 20190009
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of …
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of …
Amgen 20190014
A Phase 4, Multi-center Open-label Feasibility Study to Evaluate Outpatient Blinatumomab Administration …
A Phase 4, Multi-center Open-label Feasibility Study to Evaluate Outpatient Blinatumomab Administration …
Apollomics APL 101-01
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, …
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, …
Arcus AB122CSP0002
A Phase 1b Study to Evaluate the Safety and Clinical …
A Phase 1b Study to Evaluate the Safety and Clinical …
Bayer DaroAct 20609
Bayer 20609, "A randomized, open-label, multicenter, Phase 2b study to …
Bayer 20609, "A randomized, open-label, multicenter, Phase 2b study to …
BMS CA209-914
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
CA224-104
A Phase 2 Randomized Double-blind Study of Relatlimab plus Nivolumab …
A Phase 2 Randomized Double-blind Study of Relatlimab plus Nivolumab …
CCTG MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
Conjupro UV1-202
A Randomized Phase II, Open‑label, Active‑controlled, Multicenter Study Investigating the Efficacy …
A Randomized Phase II, Open‑label, Active‑controlled, Multicenter Study Investigating the Efficacy …
E4412
A Phase I Study with an Expansion Cohort/Randomized Phase II …
A Phase I Study with an Expansion Cohort/Randomized Phase II …
E4512
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
EA1131
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
EA2176
A Phase III Study of Immune checkpoint inhibition with chemotherapy …
A Phase III Study of Immune checkpoint inhibition with chemotherapy …
EA2182
A Randomized Phase II Study of De-intensified Chemoradiation for Early …
A Randomized Phase II Study of De-intensified Chemoradiation for Early …
EA3161
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA4151
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA6134
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA6141
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim …
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim …
EA8143
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA9131
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EA9161
EA9161 - A Randomized Phase III Study of the Addition …
EA9161 - A Randomized Phase III Study of the Addition …
EAA181
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase …
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase …
EFC15858
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel …
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel …
Galera GTI 4419-301
ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – …
ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – …
Galera GTI-4419-203
A Phase 2A Open-Label Trial of the Effects of Intravenous …
A Phase 2A Open-Label Trial of the Effects of Intravenous …
GOG 0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
GSK 209229
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or …
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or …
Merck MK3475-667
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) …
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) …
Merck MK3475-671
A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy …
A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy …
Merck MK3475-966
A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus …
A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus …
MK 3475-905
A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab …
A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab …
MK 4375-992
A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study …
A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study …
MK 7339-013
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) …
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) …
NCICOVID
COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History …
COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History …
NHLBI-MDS
The National Myelodysplastic Syndromes (MDS) Study
The National Myelodysplastic Syndromes (MDS) Study
NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
NRG GY006
A Randomized Phase II Trial of Radiation Therapy and Cisplatin …
A Randomized Phase II Trial of Radiation Therapy and Cisplatin …
NRG LU005
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III …
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III …
NRG LU007
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for …
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for …
NRG-CC004
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-GU002
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-LU002
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
PUMA NER-5201
AN OPEN-LABEL, PHASE 2 STUDY OF NERATINIB IN PATIENTS WITH …
AN OPEN-LABEL, PHASE 2 STUDY OF NERATINIB IN PATIENTS WITH …
QUILT 2.023
A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY OF N-803, A FUSION …
A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY OF N-803, A FUSION …
QUILT 3.055
A Phase 2b, Single-Arm, Multicohort, Open-Label Study of ALT-803 in …
A Phase 2b, Single-Arm, Multicohort, Open-Label Study of ALT-803 in …
S1608
Randomized Phase II Trial in Early Relapsing or Refractory Follicular …
Randomized Phase II Trial in Early Relapsing or Refractory Follicular …
S1609
DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors | …
DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors | …
S1801
S1801 - A Phase II Randomized Study of Adjuvant Versus …
S1801 - A Phase II Randomized Study of Adjuvant Versus …
S1803
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or …
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or …
SGN22E-002 (EV-103)
A study of enfortumab vedotin (ASG-22CE) as monotherapy or in …
A study of enfortumab vedotin (ASG-22CE) as monotherapy or in …
SGNLVA-005
Open Label Phase II Study of Ladiratuzumab Vedotin (LV) for …
Open Label Phase II Study of Ladiratuzumab Vedotin (LV) for …
SLS18-301
Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S …
Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S …
SWOG S1714
S1714 - A Prospective Observational Cohort Study to Develop a …
S1714 - A Prospective Observational Cohort Study to Develop a …
SWOG S1826
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
URCC 18007
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue | >>Read …
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue | >>Read …
WF-1802
Influence of Primary Treatment for Prostate Cancer on Work Experience …
Influence of Primary Treatment for Prostate Cancer on Work Experience …
WF-1805
WF-1805 - Implementation and Effectiveness Trial of HN-STAR | >>Read …
WF-1805 - Implementation and Effectiveness Trial of HN-STAR | >>Read …
Appointments Available
Request an appointment
Schedule Now
Information Hotline
Have a question? Call us at:
(864) 603-6200
